94 related articles for article (PubMed ID: 6158597)
1. [Selective staining of T-lymphoblastic leukemia cells by glycyl-prolyl-4-methoxy-beta-naphthylamiden-peptidase (DAP IV) (author's transl)].
Feller AC; Parwaresch MR
Klin Padiatr; 1980 Mar; 192(2):150-3. PubMed ID: 6158597
[TBL] [Abstract][Full Text] [Related]
2. Enzymehistochemical staining of T mu lymphocytes for glycyl-proline-4-methoxy-beta-naphthylamide-peptidase (DAP IV).
Feller AC; Heijnen CJ; Ballieux RE; Parwaresch MR
Br J Haematol; 1982 Jun; 51(2):227-34. PubMed ID: 6123345
[TBL] [Abstract][Full Text] [Related]
3. Cytochemical distribution of dipeptidylaminopeptidase IV (DAP IV; EC-3.4.14.5) in T-lymphoblastic lymphoma/leukemia characterized with monoclonal antibodies.
Feller AC; Parwaresch MR; Lennert K
Leuk Res; 1984; 8(3):397-406. PubMed ID: 6379309
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dipeptidyl peptidase IV from lymphocytes of chronic lymphocytic leukemia of T-type.
Mentlein R; Rix H; Feller AC; Heymann E
Biomed Biochim Acta; 1986; 45(5):567-74. PubMed ID: 2875712
[TBL] [Abstract][Full Text] [Related]
5. Cytochemistry of dipeptidylaminopeptidase IV in T lymphoblastic leukaemia-lymphoma.
Invernizzi R; Perugini O; De Fazio P; Bonetti F; Nespoli BL
Haematologia (Budap); 1989; 22(3):143-9. PubMed ID: 2573567
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV in human T-lymphocytes: cytochemical and histochemical investigations in patients with non-Hodgkin's lymphoma.
Schön E; Essbach U; Machura R; Franke A; Ansorge S
Acta Histochem Suppl; 1986; 33():131-8. PubMed ID: 2874587
[TBL] [Abstract][Full Text] [Related]
7. Enzymecytochemical heterogeneity of human chronic T-lymphocytic leukemia as demonstrated by reactivity to dipeptidylaminopeptidase IV (DAP IV; EC 3.4.14.4).
Feller AC; Parwaresch MR; Bartels H; Lennert K
Leuk Res; 1982; 6(6):801-8. PubMed ID: 6759796
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase IV activity in cells of T-lymphoid origin is decreased in cultures with 12-0-tetradecanoylphorbol-13-acetate (TPA).
Lemez P; Koubek K; Malasková V; Lojda Z
Haematologia (Budap); 1987; 20(3):165-70. PubMed ID: 2891591
[TBL] [Abstract][Full Text] [Related]
9. [Dipeptidyl aminopeptidase-IV in lymphocytes of patients with lymphoproliferative diseases].
Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
Biull Eksp Biol Med; 1989 Jul; 108(7):85-8. PubMed ID: 2572281
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
11. [In situ - demonstration of helper-T-lymphocytes in cutaneous malignant lymphomas by diaminopeptidase IV (DAP IV)].
Sterry W; Steigleder GK; Goos M; Meisterernst E
Z Hautkr; 1982 Apr; 57(8):567-76. PubMed ID: 6124066
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidylaminopeptidase IV (DAP IV) in B- and T-cell leukaemias.
Andrews C; Crockard AD; San Miguel JF; Catovsky D
Clin Lab Haematol; 1985; 7(4):359-68. PubMed ID: 2869856
[TBL] [Abstract][Full Text] [Related]
13. Comparative cytochemical study of dipeptidyl aminopeptidase (DAP) II and IV in normal and malignant haemic cells.
Khalaf MR; Bevan PC; Hayhoe FG
J Clin Pathol; 1986 Aug; 39(8):891-6. PubMed ID: 2875085
[TBL] [Abstract][Full Text] [Related]
14. [Lymphoblastic lymphomas in children. Their recognizability as T- or B-cell neoplasms in histologic slides (routine sections) (author's transl)].
Schwarze EW; Pileri S; Tolksdorf G; Kampert-Blumberg J
Klin Padiatr; 1981 May; 193(3):131-6. PubMed ID: 6973667
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl(amino)peptidase IV (DAP-IV) histochemistry on normal and pathologic lymphoid tissues.
Chilosi M; Pizzolo G; Menestrina F; Iannucci AM; Bonetti F; Fiore-Donati L
Am J Clin Pathol; 1982 Jun; 77(6):714-9. PubMed ID: 7046417
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo.
Ahmad S; Wang L; Ward PE
J Pharmacol Exp Ther; 1992 Mar; 260(3):1257-61. PubMed ID: 1372050
[TBL] [Abstract][Full Text] [Related]
17. [Immunological cell markers on lymphoblasts of patients with acid phosphatase positive acute leukemia (author's transl)].
Ritter J; Gaedicke G; Winkler K; Landbeck G
Z Kinderheilkd; 1975 Sep; 120(3):211-5. PubMed ID: 1080934
[TBL] [Abstract][Full Text] [Related]
18. [Dipeptidyl peptidase IV of peripheral blood lymphocytes in patients with primary biliary cirrhosis].
Adler D; Kürktschiev D; Subat S; Lehmann HU; Schentke KU
Z Gastroenterol; 1993 Feb; 31(2):135-9. PubMed ID: 8096665
[TBL] [Abstract][Full Text] [Related]
19. Subtyping of chronic lymphocytic leukemia of T-type by dipeptidylaminopeptidase IV (DAP IV), monoclonal antibodies, and Fc-receptors.
Feller AC; Parwaresch MR; Lennert K
Cancer; 1983 Nov; 52(9):1609-12. PubMed ID: 6137274
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidylaminopeptidase IV activity in normal and leukemic T-cell subpopulations.
Crockard AD; MacFarlane E; Andrews C; Bridges JM; Catovsky D
Am J Clin Pathol; 1984 Sep; 82(3):294-9. PubMed ID: 6380269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
